Search
Uromitexan

Uromitexan

mesna

Manufacturer:

Baxter Healthcare

Distributor:

Baxter Healthcare
/
Firma Chun Cheong
Concise Prescribing Info
Contents
Mesna
Indications/Uses
Prevention of urothelial toxicity due to oxazaphosphorines.
Click to view Uromitexan detailed prescribing information
Dosage/Direction for Use
Adult 20% of oxazaphosphorine dose at time 0 (time of oxazaphosphorine inj) & then at 4 & 8 hr IV.
Click to view Uromitexan detailed prescribing information
Warnings
For additional cautionary notes to warn of the potential risk of using the medicine... Click to view Uromitexan detailed prescribing information
Special Precautions
Hypersensitivity reactions in patients w/ autoimmune disorders. Protective effect applies only to the urinary tract. Pregnancy & lactation.
Click to view Uromitexan detailed prescribing information
Adverse Reactions
Hypersensitivity & inj reactions, GI effects, headache, pain in limb, decrease BP, tachycardia, skin reactions, exhaustion & weakness.
Drug Interactions
Incompatible w/ cisplatin, carboplatin, nitrogen mustard.
Click to view Uromitexan detailed prescribing information
Caution For Usage
For caution against possible variation of physical aspect of medicine... Click to view Uromitexan detailed prescribing information
Description
View Uromitexan description for details of the chemical structure and excipients (inactive components).
Action
View Uromitexan mechanism of action for pharmacodynamics and pharmacokinetics details.
ATC Classification
V03AF01 - mesna ; Belongs to the class of detoxifying agents used in antineoplastic treatment.
Presentation/Packing
Form
Uromitexan inj 100 mg/mL
Packing/Price
4 mL x 15 × 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in